C4 Therapeutics (CCCC) Stock Analysis & AI Equity Report
C4 Therapeutics (CCCC) overview
C4 Therapeutics (CCCC) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 35.9m and operating profit of USD -115m; the year-end share price was 1.91 USD and market capitalisation was USD 185m. C4 Therapeutics is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get C4 Therapeutics's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
About C4 Therapeutics
C4 Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule medicines using targeted protein degradation. Its TORPEDO platform supports the design of protein degraders, including clinical candidates for multiple myeloma and non-small-cell lung cancer. The company is also pursuing discovery programs in inflammation, neuroinflammation, and neurodegeneration, and collaborates with pharmaceutical partners on degrader research and development.
Generate the C4 Therapeutics report
C4 Therapeutics is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for C4 Therapeutics and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.
Analyst reports on C4 Therapeutics
Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.